Saturday, September 4, 2021

Does the FDA think these data justify the first full approval of a covid-19 vaccine?

The FDA should demand adequate, controlled studies with long term follow up, and make data publicly available, before granting full approval to covid-19 vaccines, says Peter Doshi posted updated results for their ongoing phase 3 covid-19 vaccine trial.